Back to DEUTSCHE BANK AG\ DEUTSCHE BANK AG\

NGNENGNE
Showing 8 of 10 quarters

Position history for DEUTSCHE BANK AG\DEUTSCHE BANK AG\'s holdings in NEUROGENE INC

DEUTSCHE BANK AG\ holds 106,660 shares of NGNE (NEUROGENE INC), worth $3.4M as of 2026-Q2. The position was increased (+0.4% shares). NGNE represents 0.0% of DEUTSCHE BANK AG\'s portfolio.

Current Value

$3.4M

Current Shares

106,660

Total Value Change

-$10.7M

Total Shares Change

-227,708

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
106,660
+0.4%
$3.4M0.0%$31.45
26
2026-Q1
Increased
106,255
+24.2%
$2.1M0.0%$21.99
32
2025-Q4
Decreased
85,571
-43.8%
$1.8M0.0%$22.11
0
2025-Q3
Increased
152,284
+0.8%
$2.6M0.0%$17.71
26
2025-Q2
Increased
151,119
+0.2%
$2.3M0.0%$16.16
26
2025-Q1
Decreased
150,862
-1.0%
$1.8M0.0%$14.52
0
2024-Q4
Decreased
152,371
-54.4%
$3.5M0.0%$22.28
0
2024-Q3
Increased
334,368
+0.6%
$14M0.0%$40.33
28

Other major holders of NGNE: BlackRock Finance, Inc., RTW INVESTMENTS, LP, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used